Rating History for Entrada Therapeutics (TRDA) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/8/2026 Boobalan Pachaiyappan Downgrade Neutral
(Buy)
N/A
(N/A)
6.85
(7.24)
5.69% Details